ACM

Altium Capital Management Portfolio holdings

AUM $34.4M
This Quarter Return
+5.02%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
10 Year Return
AUM
$431M
AUM Growth
+$431M
Cap. Flow
+$69.5M
Cap. Flow %
16.11%
Top 10 Hldgs %
23.13%
Holding
178
New
54
Increased
29
Reduced
24
Closed
43
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PROF
51
Profound Medical
PROF
$135M
$3.44M 0.8%
210,280
+83,853
+66% +$1.37M
TCRR
52
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$3.43M 0.8%
209,130
GKOS icon
53
Glaukos
GKOS
$5.36B
$3.43M 0.79%
40,400
-400
-1% -$33.9K
KRMD icon
54
KORU Medical Systems
KRMD
$193M
$3.37M 0.78%
+728,487
New +$3.37M
CRDF icon
55
Cardiff Oncology
CRDF
$132M
$3.34M 0.77%
+501,878
New +$3.34M
EYPT icon
56
EyePoint Pharmaceuticals
EYPT
$820M
$3.33M 0.77%
370,551
+81,235
+28% +$730K
TBPH icon
57
Theravance Biopharma
TBPH
$702M
$3.19M 0.74%
+220,000
New +$3.19M
XENT
58
DELISTED
Intersect ENT, Inc
XENT
$3.12M 0.72%
182,456
+40,600
+29% +$694K
CLDX icon
59
Celldex Therapeutics
CLDX
$1.53B
$3.11M 0.72%
93,116
+48,103
+107% +$1.61M
AVDL
60
Avadel Pharmaceuticals
AVDL
$1.41B
$2.97M 0.69%
440,589
STIM icon
61
Neuronetics
STIM
$211M
$2.96M 0.69%
184,554
+47,054
+34% +$754K
XENE icon
62
Xenon Pharmaceuticals
XENE
$3.06B
$2.89M 0.67%
+155,000
New +$2.89M
PHAS
63
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$2.88M 0.67%
775,000
HUMA icon
64
Humacyte
HUMA
$236M
$2.8M 0.65%
+275,000
New +$2.8M
INFI
65
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$2.79M 0.65%
934,327
-38,000
-4% -$114K
KALV icon
66
KalVista Pharmaceuticals
KALV
$744M
$2.68M 0.62%
111,834
-16,296
-13% -$391K
MLTX icon
67
MoonLake Immunotherapeutics
MLTX
$3.88B
$2.59M 0.6%
250,000
TMPM
68
DELISTED
Turmeric Acquisition Corp. Class A Ordinary Shares
TMPM
$2.51M 0.58%
+254,000
New +$2.51M
SNCE
69
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2.5M 0.58%
250,000
MCRB icon
70
Seres Therapeutics
MCRB
$172M
$2.5M 0.58%
104,626
TVTX icon
71
Travere Therapeutics
TVTX
$1.69B
$2.49M 0.58%
170,484
-40,000
-19% -$584K
ADMS
72
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$2.49M 0.58%
470,949
+20,949
+5% +$111K
RGNX icon
73
Regenxbio
RGNX
$470M
$2.42M 0.56%
+62,317
New +$2.42M
SRGA
74
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$2.42M 0.56%
+1,739,131
New +$2.42M
SRSAU
75
DELISTED
Sarissa Capital Acquisition Corp. Unit
SRSAU
$2.35M 0.54%
225,000